Save time and get answers to complex questions with AI chat
Patent expiration date of guselkumab?Diltiazem drug class?Complera manufacturer?When is the expected fda decision date for apotex's ruxolitinib resubmission?What's the advised delay for milk post lipitor?
See the DrugPatentWatch profile for Neratinib
In the United States, neratinib (Nerlynx) was approved by the FDA on July 17, 2017 for extended adjuvant treatment of HER2-positive breast cancer following trastuzumab. If you need the approval date for another region (e.g., EU) or a different indication, tell me and I can look that up.
Other Questions About Neratinib :